up again (21%)
http://finance.yahoo.com/q?s=bit.ax&x=48&y=19
Analyst comment:
Biotron is inexpensive given our valuation: Based on the potential of Biotron’s compounds in HIV and Hepatitis C alone, we conservatively value the company at $1.85 base case and $4.48 optimistic case.
Biotron Limited (Bit.ax)
Marketcap: 13 million A$
Price : 14 cent
HIV trial start Phase 1b/2a in 2Q 2008 results in 3Q 2008
HCV/Hepatitis trial start Phase 1b/2a in 2Q 2008 results in 3Q 2008
- Forums
- ASX - By Stock
- hiv and hepatitis c....big market
up again...
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
0.001(2.70%) |
Mkt cap ! $34.28M |
Open | High | Low | Value | Volume |
3.7¢ | 4.0¢ | 3.7¢ | $68.85K | 1.794M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 349950 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 0.037 |
5 | 415000 | 0.036 |
5 | 724214 | 0.035 |
2 | 106000 | 0.033 |
3 | 91250 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 299950 | 2 |
0.041 | 144000 | 2 |
0.042 | 117600 | 1 |
0.043 | 102000 | 1 |
0.045 | 120000 | 1 |
Last trade - 15.10pm 28/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online